NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Acusphere, Inc.



Acusphere, Inc. Reports Q4 2008 Recent Business Highlights, Business Priorities and Financial Results



April 17th, 2009

Acusphere, Inc. (ACUS:PK) reported financial results for the fourth quarter and year ended December 31, 2008, and commented on its business and progress to date. The Company continues to discuss its New Drug Application (NDA) with the U.S. Food & Drug Administration (FDA) for its lead product candidate, ImagifyTM (Perflubutane Polymer Microspheres) for Injectable Suspension following the receipt of FDA’s complete response letter in late February. Imagify is a Perfusion Stress Echo imaging agent targeted for use in detecting coronary artery disease. Recent Business Highlights Signed an agreement to terminate and transition the Company’s Collaboration, License and Supply Agreement for...


Source: Health Business Week (2009-04-17)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login